The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  66 (2024)
Volume  65 (2023)
Volume  64 (2022)
Volume  63 (2021)
Volume  62 (2020)
Volume  61 (2019)
Volume  60 (2018)
Volume  59 (2017)
Volume  58 (2016)
Volume  57 (2015)
Volume  56 (2014)
Volume  55 (2013)
Volume  54 (2012)
Volume  53 (2011)
Volume  52 (2010)
Related articles

VOLUME 66 , ISSUE 1 ( January-March, 2024 ) > List of Articles

Original Article

Combustion of Biomass Fuel and Chronic Obstructive Pulmonary Disease in Rural Population of India

Raj Kumar, Kamal Singh, Anil K Mavi, Jitendra K Nagar, Sukriti Raj, Manoj Kumar, Ravishankar Nagaraja

Keywords : Biomass fuel, Chronic obstructive pulmonary disease, Indoor air pollution, Particulate matter

Citation Information : Kumar R, Singh K, Mavi AK, Nagar JK, Raj S, Kumar M, Nagaraja R. Combustion of Biomass Fuel and Chronic Obstructive Pulmonary Disease in Rural Population of India. Indian J Chest Dis Allied Sci 2024; 66 (1):1-6.

DOI: 10.5005/jp-journals-11007-0108

License: CC BY-NC 4.0

Published Online: 03-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background: Globally, chronic obstructive pulmonary disease (COPD) has a substantial and growing burden. Thus, among rural adults in Delhi National Capital Region (Delhi NCR), the study examines the prevalence of COPD among nonsmokers and the relationship between biomass fuel (BMF) use and COPD. Materials and methods: This cross-sectional study, conducted among adults in rural Delhi NCR areas with or without COPD, was community based. Enrolment comprised 1,564 individuals from 561 households. Information was gathered using a standard questionnaire, indoor particulate matter (PM) (PM1, PM2.5, and PM10) aerosol spectrometers were used to measure the concentrations, and pulmonary function tests (PFTs) were performed using a portable spirometry (GRIMM). Results: In adults in rural areas of Delhi NCR, 8.95% prevalence of COPD were found in which females were found significantly high COPD as compared with males (7.1% males and 92.9% females, p < 0.001). The concentration levels of PM10 (249.28 ± 189.33 vs 174.54 ± 76.40; p < 0.003), PM2.5 (134.78 ± 95.25 vs 108.66 ± 53.67; p = 0.039), and PM1 (107.22 ± 82.65 vs 89.51 ± 51.43; p = 0.025) were found significantly high in households of COPD patients as opposed to controls. Only COPD patients had airway obstruction (64.1%) as opposed to controls. Indoor air factors, that is, BMF smoke (p = 0.042), exhaust fan (0.047), and poor ventilation (p = 0.003), were found significantly associated with COPD. Conclusion: Factors such as combustion of BMF, kerosene oil, lack of exhaust fan, poor ventilation, and increased concentration of indoor PM, that could be very important in the onset of COPD in adults, especially in women and old age persons.

PDF Share
  1. World Health Organization. Chronic obstructive pulmonary disease (COPD). 2017. Available at: https://www.who.int/news-room/fact-sheets/detail/chronicobstructive-pulmonary-disease-(copd). Accessed on: 25 June 2019.
  2. Croft JB, Wheaton AG, Liu Y, et al. Urban–rural county and state differences in chronic obstructive pulmonary disease – United States, 2015. MMWR Morb Mortal Wkly Rep 2018;67(7):205–211. DOI: 10.15585/mmwr.mm6707a1.
  3. Menezes AMB, Victora CG, Perez–Padilla R, et al. The PLATINO project: Methodology of a multi-center prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 2004;4:15. DOI: 10.1186/1471-2288-4-15.
  4. Burney P, Jithoo A, Kato B, et al. Burden of obstructive lung disease (BOLD) study. Chronic obstructive pulmonary disease mortality and prevalence: The associations with smoking and poverty—a BOLD analysis. Thorax 2014;69(5):465–473. DOI: 10.1136/thoraxjnl-2013-204460.
  5. Murray CJ, Lopez AD. Alternative projection of mortality by cause 1990–2020: Global burden of disease study. Lancet 1997;349(9064):1498–1504. DOI: 10.1016/S0140-6736(96)07492-2.
  6. Kurmi OM, Lam KBH, Ayres JG. Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J 2012;40(1):239–254. DOI: 10.1183/09031936.00190211.
  7. Rafael LL. Smoking and chronic obstructive pulmonary disease (COPD). Parallel Epidemics of the 21st Century. Int J Environ Res Public Health 2009;6(1):209–224. DOI: 10.3390/ijerph6010209.
  8. Olloquequi J, Jaime S, Parra V, et al. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both. Respir Res 2018;19(1):13. DOI: 10.1186/s12931-018-0718-y.
  9. World Health Organization. Household air pollution and health. COPD. 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/household-air-pollution-and-health.
  10. Smith KR, Sundell J. Human exposures to combustion products from household use of unprocessed solid fuels (biomass and coal) in simple stoves are substantial sources of ill-health in a world perspective. Indoor Air 2002;12(3):145–146. DOI: 10.1034/j.1600-0668.2002.02002.x.
  11. Madhurmay S, Kumar H, Kumar S, et al. Study of association between exposure to indoor air pollution and chronic obstructive pulmonary disease among nonsmokers in a North Indian population: A case–control study. Indian J Respir Care 2019;8:71–75. DOI: 10.4103/ijrc.ijrc_52_18.
  12. Hu G, Zhou Y, Tian J, et al. Risk of COPD from exposure to biomass smoke: A meta-analysis. Chest 2010;138(1):20–31. DOI: 10.1378/chest.08-2114.
  13. Andreeva E, Pokhaznikova M, Lebedev A, et al. The prevalence of the chronic obstructive pulmonary disease by the global lung initiative equations in North–Western Russia. Respiration 2016;91(1):43–55. DOI: 10.1159/000442887.
  14. Magitta NF, Walker RW, Apte KK, et al. Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania. Eur Respir J 2018;51:1700182. DOI: 10.1183/13993003.00182-2017.
  15. Osunsanya T, Prescott G, Seaton A. Acute respiratory effects of particles: Mass or number? Occup Environ Med 2001;58:154–159. DOI: 10.1136/oem.58.3.154.
  16. Liu S, Zhou Y, Wang X, et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 2007;62(10):889–897. DOI: 10.1136/thx.2006.061457.
  17. Viegi G, Maio S, Pistelli F, et al. Epidemiology of chronic obstructive pulmonary disease: Health effects of air pollution. Respirology 2006;11(5):523–532. DOI: 10.1111/j.1440-1843.2006.00886.x.
  18. Ekici A, Ekici M, Kurtipek E, et al. Obstructive airway diseases in women exposed to biomass smoke. Environ Res 2005;99(1):93–98. DOI: 10.1016/j.envres.2005.01.004.
  19. Torres DC, Maldonado D, Perez–Padilla R, et al. Biomass fuels and respiratory diseases: A review of the evidence. Proc Am Thorac Soc 2008;5(5):577–590. DOI: 10.1513/pats.200707-100RP.
  20. Global Initiative for Chronic Obstructive Lung Disease (GOLD guideline – 2018). Global strategy for the diagnosis, management, and prevention of COPD. Available at: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2018.
  21. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948–968. DOI: 10.1183/09031936.05.00035205.
  22. Prasad JS, Anand PRV, Supriya A, et al. Impact of biogas as predisposing factors upon bronchial asthma (BA) and chronic obstructive pulmonary disorder (COPD) among housewives. Int J Pharm Sci Res 2019;10(1):445–450. DOI: 10.13040/IJPSR.0975-8232.10(1).445-50.
  23. Sana A, Somda SMA, Meda N, et al. Chronic obstructive pulmonary disease associated with biomass fuel use in women: A systematic review and metanalysis. BMJ Open Resp Res 2018;5(1):e000246. DOI: 10.1136/bmjresp-2017-000246.
  24. Wheaton AG, Cunningham TJ, Ford ES, et al; Centers for Disease Control and Prevention (CDC) Employment and activity limitations among adults with chronic obstructive pulmonary disease – United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64(11):289–295. PMID: 25811677.
  25. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374(9691):733–743. DOI: 10.1016/S0140-6736(09)61303-9.
  26. Smith M, Li L, Augustyn M, et al. Prevalence and correlates of airflow obstruction in approximately 317,000 never-smokers in China. Eur Respir J 2014;44(1):66–77. DOI: 10.1183/09031936.00152413.
  27. Deepali RG. COPD in non-smoker women with biomass fuel exposure (Chulha): A review article. Int J Innov Res Med Sci 2017;2(4): 643–644. DOI: 10.23958/ijirms/vol02-i04/01.
  28. Fullerton DG, Suseno A, Semple S, et al. Wood smoke exposure, poverty and impaired lung function in Malawian adults. Int J Tuberc Lung Dis 2011;15(3):391–398. PMID: 21333109.
  29. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367(9524):1747–1757. DOI: 10.1016/S0140-6736(06)68770-9.
  30. Balmes JR. When smoke gets in your lungs. Proc Am Thorac Soc 2010;7(2):98–101. DOI: 10.1513/pats.200907-081RM.
  31. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev 2009;18(114):213–221. DOI: 1183/09059180.00003609.
  32. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532–555. DOI: 10.1164/rccm.200703-456SO.
  33. Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007;370:765(9589):765–773. DOI: 10.1016/S0140-6736(07)61380-4.
  34. Sutradhar I, Gupta RD, Hasan M, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in Bangladesh: A systematic review. Cureus 2019;11(1):e3970. DOI: 10.7759/cureus.3970.
  35. Alam DS, Chowdhury MA, Siddiquee AT, et al. Prevalence and determinants of chronic obstructive pulmonary disease (COPD) in Bangladesh. COPD: J Chron Obstruct Pulmon Dis 2015;12(6):658–667. DOI: 10.3109/15412555.2015.1041101.
  36. Nugmanova D, Feshchenko Y, Iashyna L, et al. The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in commonwealth of independent states (Ukraine, Kazakhstan and Azerbaijan): Results of the CORE study. BMC Pulm Med 2018;18(1):26. DOI: 10.1186/s12890-018-0589-5.
  37. Tan WC, Sin DD, Bourbeau J, et al. Can COLD Collaborative Research Group. Characteristics of COPD in never-smokers and ever-smokers in the general population: Results from the Can COLD study. Thorax 2015;70(9):822–829. DOI: 10.1136/thoraxjnl-2015-206938.
  38. Bhatt SP, Kim YI, Harrington KF, et al. Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years. Thorax 2018;73(5):414–421. DOI: 10.1136/thoraxjnl-2017-210722.
  39. Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest 2010;138(1):3–6. DOI: 10.1378/chest.10-0645.
  40. Jin JM, Sun YC. Allergy and chronic obstructive pulmonary disease. Chin Med J (Engl) 2017;130(17):2017–2020. DOI: 10.4103/0366-6999.213427.
  41. Jamieson DB, Matsui EC, Belli A, et al. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188(2):187–192. DOI: 10.1164/rccm.201211-2103OC.
  42. Morantes–Caballero JA, Rodriguez HAF. Effects of air pollution on acute exacerbation of chronic obstructive pulmonary disease: A descriptive retrospective study (pol-AECOPD). Int J Chron Obstruct Pulmon Dis 2019;14:1549–1557. DOI: 10.2147/COPD.S192047.
  43. Zhao J, Li M, Wang Z, et al. Role of PM 2.5 in the development and progression of COPD and its mechanisms. Resp Res 2019;20(1):120. DOI: 10.1186/s12931-019-1081-3.
  44. Lei Ni, Chuang CC, Zuo L. Fine particulate matter in acute exacerbation of COPD. Front Physiol 2015;6:294. DOI: 10.3389/fphys.2015.00294.
  45. Li G, Huang J, Xu G, et al. The short-term burden of ambient fine particulate matter on chronic obstructive pulmonary disease in Ningbo, China. Environ Health 2017;16(1):54. DOI: 10.1186/s12940-017-0253-1.
  46. Tao Li, Rong Hu, Zi Chen, et al. Fine particulate matter (PM2.5): The culprit for chronic lung diseases in China. Chronic Dis Transl Med 2018;4(3):176–186. DOI: 10.1016/j.cdtm.2018.07.002.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.